Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort studyWaasila Jassat, Shireen Arends, Cheryl Cohen et al.|The Lancet HIV|2021Cited by 180
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Imran Zainal Abidin, Ciaran J. McMullan et al.|The Lancet|2025Cited by 77
Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern AfricaEliane Rohner, Julia Bohlius, Matthias Egger et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2014Cited by 61
A national cohort study of COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence settingWaasila Jassat, Lucille Blumberg, Cheryl Cohen et al.|medRxiv|2020Cited by 21
COVID-19 In-Hospital Mortality in South Africa: The Intersection of Communicable and Non-Communicable Chronic Diseases in a High HIV Prevalence SettingWaasila Jassat, Cheryl Cohen, Stefano Tempia et al.|SSRN Electronic Journal|2021Cited by 11